Skip to content

A randomized study for running suture versus conventional interrupted suture for vesico-urethral anastomosis in patients with retropubic radical prostatectomy

A randomized study for running suture versus conventional interrupted suture for vesico-urethral anastomosis in patients with retropubic radical prostatectomy - Running suture vs. interrupted suture in radical prostatectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000007883
Enrollment
60
Registered
2012-05-02
Start date
2010-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Interventions

1) A number of cases: 60 2) The study period: 3 years (October 2010 to September 2013) Method 1) After we obtain informed consents, we assigned to two groups, interrupted suture or running suture
s wishes, we must describe a statement to that effect. 4) Basically, date of discharge is the next day of catheter removal. It depends on general condition and patient&#39
s wishes. 5) Interrupted suture is performed by conventional 6 points, 1, 3, 5, 7, 9, 11, o&#39
clock interrupted suture using 2-0 polyglactin. Running suture was performed by 12 bite sutures starting from 6 to 12 o&#39
clock direction using 3-0 poliglecaprone. Social continence rate is described, 0 or 1 pad a day, at 1, 3, 6 and 12 months after surgery. 1) A number of cases: 60 2) The study period: 3 years (October

Sponsors

Graduate School of Medicine Yamaguchi University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 60 patients who will plan to perform radical prostatectomy for organ confined disease; the informed consents must be obtained from those patients. (Regardless of age)

Exclusion criteria

Exclusion criteria: 1) Patients with a history of a urethral stricture. 2) Patients with a history of central nervous system damage such as cerebral hemorrhage and cerebral infarction. 3) Patients with peripheral neuropathy such as diabetes and rectal cancer surgery. 4) Patients with a history of bladder cancer and cancer of the urethra. 5) Patients whom physician may find to be inappropriate.

Design outcomes

Primary

MeasureTime frame
The period from post operation to removal of urethral catheter

Secondary

MeasureTime frame
1. Duration of hospitalization 2. Frequency of leakage of contrast medium at the time of cystography 3. Rate of urinary incontinence after catheter removal 4. Frequency of postoperative complications

Countries

Japan

Contacts

Public ContactHiroaki Matsumoto

Graduate School of Medicine Yamaguchi University Urology

yu.uro@yamaguchi-u.ac.jp0836-22-2275

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026